(NEW YORK) -- Moderna announced Tuesday it has dosed its first participant in a phase III clinical trial of a combination influenza and COVID-19 vaccine.This phase will evaluate the safety and efficacy of the combo vaccine compared to flu and COVID vaccines that are... Read More.
(ATLANTA) -- The mpox vaccination campaign after an outbreak swept the United States last year was highly effective at preventing infection, new federal data showed.One dose of the JYNNEOS vaccine was 75% effective and two doses of the vaccine were 86% effective, a new... Read More.
(NEW YORK) -- Following its emergency authorization last month, just 7,300 doses of Novavax's COVID-19 vaccine have been administered to Americans across the country, newly updated data from the Centers for Disease Control and Prevention (CDC) reveals.According to John Brownstein, Ph.D., an epidemiologist at Boston... Read More.
Wesley Lapointe / Los Angeles Times via Getty Images)(NEW YORK) -- Since the COVID-19 vaccine was authorized for children under age 5 last month, states have been able to pre-order doses directly from the federal government.Roughly 300,000 children between ages six months and four... Read More.
(WASHINGTON) -- The Biden administration is planning to send out hundreds of thousands of monkeypox vaccines in response to the outbreak of the rare disease that has been identified in multiple non-endemic countries.The Department of Health and Human Services announced Tuesday on a call... Read More.
(NEW YORK) -- Even as most eligible Americans have yet to receive their first COVID-19 vaccine boosters, Pfizer and Moderna have now asked the Food and Drug Administration to authorize yet another booster dose -- especially for elderly Americans, a group that tends to... Read More.
(NEW YORK) -- COVID-19 vaccines for kids under 5 have not yet been authorized, but the U.S.' rollout plan is already in the works.The federal government is prepping an initial 10 million doses of the under-5 Pfizer formula, which will be ready to go... Read More.
(NEW YORK) -- A real-world study of South African health care workers found that two doses of the Johnson & Johnson COVID-19 vaccine offer 85% protection against hospitalization from the omicron variant.Separately, the company announced new data from a laboratory study that shows its... Read More.
(ATLANTA) -- CDC Director Rochelle Walensky gave the final signoff on Thursday evening to recommend both Moderna and Johnson & Johnson vaccine boosters for certain populations.The CDC's independent panel voted unanimously to support that decision earlier Thursday.The panel recommended a third dose for Moderna... Read More.
(ATLANTA) -- An independent Centers for Disease Control and Prevention advisory committee on Thursday is set to discuss and vote on booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines, along with the potential for people to mix and match their booster... Read More.
(WASHINGTON) — Pfizer CEO Albert Bourla said on ABC's "This Week" Sunday it's possible to provide both COVID-19 booster shots as well as doses for people who have not yet been vaccinated."I think it is also not the right thing to try to resolve... Read More.
(NEW YORK) -- Pfizer just released its first safety data about COVID-19 vaccines for children ages 5 to 11, reassuring parents that a safe and effective vaccine soon could be available for those younger than 12.A trial of 2,268 children showed that a smaller... Read More.